Skip to main content
Livermore
Livermore
ZHEN

Ancora Advisors, LLC

SEC CIK
0001446114
Latest filing
Aug 14, 2026

GSK holding history

GSK plc in every 13F filed by Ancora Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
1,362
Value
$71.4K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of GSK by Ancora Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,362$71.4K<0.1%−3,955−74.4%ReducedHolders
Q1 20265,317$293.4K<0.1%+1,600+43.0%AddedHolders
Q4 20253,717$182.3K<0.1%+1,094+41.7%AddedHolders
Q3 20252,623$113.2K<0.1%−600−18.6%ReducedHolders
Q2 20253,223$123.8K<0.1%+57+1.8%AddedHolders
Q1 20253,166$122.7K<0.1%−9,805−75.6%ReducedHolders
Q4 202412,971$438.7K<0.1%−2,989−18.7%ReducedHolders
Q3 202415,960$652.5K<0.1%−536−3.2%ReducedHolders
Q2 202416,496$635.1K<0.1%+1,054+6.8%AddedHolders
Q1 202415,442$662.0K<0.1%+599+4.0%AddedHolders
Q4 202314,843$550.1K<0.1%+1,551+11.7%AddedHolders
Q3 202313,292$481.8K<0.1%+635+5.0%AddedHolders
Q2 202312,657$451.1K<0.1%+1,001+8.6%AddedHolders
Q1 202311,656$414.7K<0.1%+9,129+361.3%AddedHolders
Q4 20222,527$89.0K<0.1%+600+31.1%AddedHolders
Q3 20221,927$57.0K<0.1%−485−20.1%ReducedHolders
Q2 20222,412$105.0K<0.1%−1,295−34.9%ReducedHolders
Q1 20223,707$161.0K<0.1%00.0%UnchangedHolders
Q4 20213,707$163.0K<0.1%−473−11.3%ReducedHolders
Q3 20214,180$160.0K<0.1%−4,440−51.5%ReducedHolders
Q2 20218,620$344.0K<0.1%00.0%UnchangedHolders
Q1 20218,620$307.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.